Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Financials · ·
$270.43
▼ $0.01 (-0.0%)
Market data updated: 09/17 10:01 AM
Fundamentals updated: 09/16/2026
News analyzed: 09/17/2026
Market Cap
$28.24B
Day Range
$266.17 - $276.20
52-Week Range
$227.15 - $371.18
Beta
—
Next Earnings
29.10.2026
CBOE is a stock from the Financials sector — Banks, insurance, and asset management — profitability sensitive to interest rates and credit cycles.
+15.7% (1Y)
Strengths: 17/32 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Earnings per share (EPS) growth
Earnings per share (EPS) growth: 44.5%
Growth
Biggest negative driver
Price vs. SMA 50
Price is below the 50-day average
Technical
What to watch next
When today echoes the past.
79/100
Similarity
15
Historical Matches
89/100
Analog Quality
+7.8%
Median 40D Outcome
54/100
Pattern Consistency
🟢 Bullish
67%
+2.8% … +15.5%
🟡 Base
0%
— … —
🔴 Bearish
33%
-5.8% … -2.7%
Typical timeframe (based on real historical rates clearing a 60% bar): 5 trading days.
📌 Bottom line: Out of 15 similar historical cases for this stock, 67% (95% CI 42%–85%) saw the stock rise within 20 trading days, with a median gain of +2.5%.
Historical outcome rate is not a probability — it's what happened in this specific historical sample, with a 95% confidence range.
| Horizon | Positive rate (95% CI) | Median | 25th–75th pct | Baseline median |
|---|---|---|---|---|
| 5D | 67% (42%–85%) | +2.9% | -0.3% … +4.9% | +0.4% |
| 10D | 53% (30%–75%) | +1.1% | -2.4% … +6.1% | +0.8% |
| 20D | 67% (42%–85%) | +2.5% | -2.5% … +9.3% | +1.6% |
| 40D | 73% (48%–89%) | +7.8% | +0.5% … +11.9% | +3.1% |
| 60D | 60% (36%–80%) | +2.3% | -3.0% … +13.6% | +4.0% |
Sample size: 15 analogs, each at least 10 trading days apart (no double-counted overlapping events).
What happened after each historical match (20-day return)
| Date | Similarity | Regime | 20D outcome | 60D outcome |
|---|---|---|---|---|
| 2020-06-24 | 79/100 | ✓ Downtrend | -2.7% | -3.1% |
| 2018-12-26 | 71/100 | Downtrend | +2.0% | +1.2% |
| 2020-07-09 | 69/100 | Downtrend | -5.8% | -3.0% |
| 2018-10-03 | 68/100 | Downtrend | +18.0% | +2.3% |
| 2021-02-11 | 66/100 | Downtrend | +18.6% | +25.7% |
| 2020-03-10 | 65/100 | Downtrend | -15.7% | -8.9% |
| 2020-10-08 | 65/100 | Downtrend | -2.3% | +8.8% |
| 2026-03-27 | 64/100 | Consolidation | +9.3% | -8.6% |
| 2024-12-19 | 64/100 | Consolidation | +2.0% | +13.2% |
| 2018-04-11 | 64/100 | ✓ Downtrend | -4.2% | -7.1% |
| 2018-05-29 | 63/100 | ✓ Downtrend | +3.7% | -2.8% |
| 2021-01-27 | 63/100 | Consolidation | +9.2% | +14.0% |
| 2022-05-12 | 62/100 | Downtrend | +2.5% | +10.9% |
| 2021-03-30 | 62/100 | Consolidation | +5.7% | +24.6% |
| 2020-12-11 | 61/100 | Consolidation | +17.5% | +19.4% |
Every accepted match is compared to today across 6 domains (price structure, momentum, technical, volatility, volume, relative strength) using z-scored feature distances — no single indicator dominates. Matches within 10 trading days of each other count as one event, not independent evidence. Outcome rates use a Wilson confidence interval (never a raw percentage alone), the mean return is winsorized against extreme outliers, and "Analog Quality" separately captures sample size, data completeness, and regime match — distinct from raw similarity. Relative strength is measured against SPY and against XLF (this stock's sector).
Cross-stock analogs — real other companies, not this stock's own history.
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
62
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🕰️ StockIQ Time Machine
What did StockIQ know — and when? Pick a date from the real accumulated history.
As of August 22, 2026
Then
68
$300.74
Now
62
$270.43
What happened since
Signals detected by this date
No signals detected by this date
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
79
Quality
63
Value
50
Momentum
26
Risk
62
Sentiment
100
Fundamental
86
Institutional
0
Stocks with a similar DNA right now
SCANNING CBOE...
Recent media coverage of **Cboe Global Markets** has primarily focused on its trading volume performance, with August 2026 reports highlighting robust activity across its global business lines. Additionally, headlines mention broader market trends, such as the potential expansion of 24-hour trading in U.S. equities—where Cboe is involved alongside Nasdaq and the SEC—and record-breaking options volume, which benefits exchanges like Cboe. No direct Cboe-specific controversies or major strategic shifts were noted in the provided sources.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Cboe Global Markets. News trend score: 100. Reason: 13 of the last 20 articles are positive, versus 0 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
26
🎯 Conviction (vs. Emotion)
42
Psychology
29
Fundamentals
86
Technical
26
Valuation
50
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
The price rise has far outpaced the actual improvement in fundamental data.
Price (3M)
+9%
Market Narrative
47
Fundamental Reality
42
Narrative Gap
+5
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior suggests detached optimism (Euphoria) driven by a 4% premium to DCF fair value, despite weak momentum and neutral RSI. Overconfidence is modest, likely tied to EPS growth outpacing price gains. The narrative-reality gap (19 points) implies investors may be overestimating fundamentals. Key question: Will the premium to fair value persist if momentum fails to improve? The absence of panic or herding signals stability, but FOMO’s low score suggests excitement is muted.
Updated: 09/09/2026, 02:14 PM
What could change this?
👥 What the crowd believes
"SEC, Nasdaq and Cboe extend hours—learn impacts on price discovery, market data and clearing"
"Options trading is booming again. New highs in volume are lifting exchange profits"
"SEC’s broad review of 'novel ETFs' could slow product launches"
📈 14D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 97/100
🔴 Weakest match
Jesse Livermore — 13/100
🗣️ Why do they disagree?
The stark divide in verdicts for CBOE reflects deep philosophical splits between growth-focused and value-oriented investors. At the top, Smith, Lynch, and Fisher—all drawn to high-quality companies with long-term potential—see CBOE as a standout buy, praising its fundamentals, growth alignment, and exceptional quality. Meanwhile, Graham and his defensive framework dismiss it outright, arguing the stock lacks the margin of safety or statistical undervaluation required for his approach. The middle ground, where Marks, Housel, and Bagehot land, acknowledges strengths like liquidity and steady growth but warns of overvaluation or inflated expectations. Even the contrarian Livermore and Schwager’s trend-following discipline reject it, while the efficient-market camp sees no clear edge over passive indexing. The debate hinges on whether CBOE’s momentum and industry leadership justify its premium—or if it’s a speculative bet rather than a value play.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 97
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 88
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 88
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟢 82
Exceptional company quality by Fisher's standards
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 80
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟢 79
Strong liquidity — would likely survive a real credit squeeze
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟢 71
Growth appears aligned with real value creation
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 69
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟡 61
Moderate — holdable, but not effortless
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 58
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 58
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 53
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 53
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🔴 34
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 31
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 13
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Based on the last 300 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (1 bullish · 8 bearish · 2 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
51.5%
Operating Margin
31.1%
Net Margin
23.3%
EBITDA Margin
33.7%
ROE
21.4%
ROA
11.8%
ROIC
—
EPS
$10.46
Cash
$2.22B
Total Debt
$1.44B
Current Ratio
1.87
Debt/Equity
0.28
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 31.8.2026 | $0.860 |
| 29.5.2026 | $0.720 |
| 28.5.2026 | $0.720 |
| 27.2.2026 | $0.720 |
| 26.2.2026 | $0.720 |
| 30.5.2025 | $0.630 |
| 29.5.2025 | $0.630 |
| 28.2.2025 | $0.630 |
| 27.2.2025 | $0.630 |
| 29.11.2024 | $0.630 |
| 28.11.2024 | $0.630 |
| 30.8.2024 | $0.630 |
How is Fair Value calculated? →
Current Price
$270.43
Estimated Fair Value (DCF)
$282.52
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
+4.5%
🟢 Appears cheap relative to estimated value
Year 1 Growth Rate
6.3%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 6.3% | $1.79B | $1.64B |
| 2 | 5.4% | $1.88B | $1.59B |
| 3 | 4.4% | $1.97B | $1.52B |
| 4 | 3.5% | $2.03B | $1.44B |
| 5 | 2.5% | $2.09B | $1.36B |
Base FCF (last actual year)
$1.68B
Terminal Value
$32.89B
Present Value of Terminal Value
$21.38B
Enterprise Value
$28.92B
Net Debt
$-773.60M
Equity Value
$29.69B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$48.89
Tangible Book Value per Share (Tangible NAV)
$6.57
Sentiment based on basic keywords (not AI) — 13 positive, 7 neutral, 0 negative out of the last 20 articles.
SeekingAlpha · 16.9.2026
SeekingAlpha · 16.9.2026
SeekingAlpha · 16.9.2026
Yahoo · 16.9.2026
ChartMill · 15.9.2026
Yahoo · 14.9.2026
ChartMill · 11.9.2026
SeekingAlpha · 11.9.2026
Yahoo · 10.9.2026
PR Newswire · 10.9.2026
Yahoo · 7.9.2026
Zacks · 7.9.2026
Yahoo · 5.9.2026
Motley Fool · 5.9.2026
SeekingAlpha · 5.9.2026
Yahoo · 4.9.2026
Motley Fool · 4.9.2026
Yahoo · 3.9.2026
PR Newswire · 3.9.2026
Yahoo · 3.9.2026
Cboe Global Markets (CBOE) currently has a StockIQ AI score of 62/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
CBOE currently scores 62/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, CBOE's estimated fair value is $282.52, which is 4.5% above the current price of $270.43. This is one valuation model among several signals in the fair-value category, not a price target.
CBOE's technical score is 26/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Earnings per share (EPS) growth: 44.5%; Free cash flow growth: 61.7%; Net income growth: 43.8%.
Based on the real signals StockIQ computed: Price is below the 50-day average; Price is below the 200-day average; MACD histogram is negative — falling momentum.
Yes — CBOE has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 4 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Fischer Heidi | Grant/Award from Employer | 19.8.2026 | 1,781 | +1,781 | — |
| Fischer Heidi | Grant/Award from Employer | 19.8.2026 | 1,119 | +1,119 | — |
| Duinstra Boudewijn | Grant/Award from Employer | 19.8.2026 | 1,069 | +1,069 | — |
| Duinstra Boudewijn | Grant/Award from Employer | 19.8.2026 | 1,335 | +1,335 | — |
| Froetscher Janet P | Open Market Sale | 12.8.2026 | 937 | -937 | $278.95 |
| Froetscher Janet P | Open Market Sale | 12.8.2026 | 12,870 | -937 | $278.95 |
| Tomczyk Fredric J | Tax Withholding in Shares | 1.7.2026 | 337 | -337 | $247.72 |
| Tomczyk Fredric J | Tax Withholding in Shares | 1.7.2026 | 35,631 | -337 | $247.72 |
| Wilkinson Allen | Grant/Award from Employer | 19.5.2026 | 166 | +166 | — |
| Wilkinson Allen | Grant/Award from Employer | 19.5.2026 | 166 | +166 | — |
| Froetscher Janet P | Open Market Sale | 18.5.2026 | 1,223 | -1,223 | $358.09 |
| Froetscher Janet P | Open Market Sale | 18.5.2026 | 13,807 | -1,223 | $358.09 |
| PALMORE RODERICK A | Grant/Award from Employer | 14.5.2026 | 530 | +530 | — |
| Tomczyk Fredric J | Grant/Award from Employer | 14.5.2026 | 530 | +530 | — |
| Froetscher Janet P | Grant/Award from Employer | 14.5.2026 | 530 | +530 | — |
| Mansfield Erin | Grant/Award from Employer | 14.5.2026 | 530 | +530 | — |
| Mao Cecilia | Grant/Award from Employer | 14.5.2026 | 530 | +530 | — |
| Farrow William M III | Grant/Award from Employer | 14.5.2026 | 530 | +530 | — |
| Goodman Jill R | Grant/Award from Employer | 14.5.2026 | 530 | +530 | — |
| Fitzpatrick Edward J. | Grant/Award from Employer | 14.5.2026 | 530 | +530 | — |
| Fong Ivan K | Grant/Award from Employer | 14.5.2026 | 530 | +530 | — |
| PALMORE RODERICK A | Grant/Award from Employer | 14.5.2026 | 27,730 | +530 | — |
| Parisi James E. | Grant/Award from Employer | 14.5.2026 | 9,969 | +530 | — |
| Farrow William M III | Grant/Award from Employer | 14.5.2026 | 12,735 | +530 | — |
| Fong Ivan K | Grant/Award from Employer | 14.5.2026 | 7,441 | +530 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
3,062,548 shares short as of 2026-08-31 · vs. 3,224,650 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
34.0% of trading volume this week was short selling, vs. 28.9% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology